| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.963 | 0.002 | 0.963 | Vasodilator, peripheral | 0.956 0.002 DBMET02637 | ||
| 0.862 | 0.003 | 0.87 | Antithrombotic | 0.87 0.003 DBMET02637 | DBMET02637 | |
| 0.858 | 0.004 | 0.884 | Platelet antagonist | 0.884 0.004 DBMET02637 | DBMET02637 | |
| 0.838 | 0.001 | 0.9 | Gastrin inhibitor | 0.9 0.001 DBMET02637 | DBMET02637 | |
| 0.795 | 0.002 | 0.795 | Gastric antisecretory | 0.739 0.002 DBMET02637 | ||
| 0.766 | 0.001 | 0.786 | Prostaglandin EP2 antagonist | 0.786 0.001 DBMET02637 | DBMET02637 | |
| 0.752 | 0 | 0.783 | Prostaglandin agonist | 0.783 0 DBMET02637 | DBMET02637 | |
| 0.753 | 0.005 | 0.753 | Spasmolytic | 0.752 0.005 DBMET02637 | ||
| 0.746 | 0.018 | 0.746 | Caspase 9 stimulant | 0.72 0.021 DBMET02637 | ||
| 0.699 | 0.005 | 0.715 | Immunosuppressant | 0.715 0.005 DBMET02637 | DBMET02637 | |
| 0.675 | 0.001 | 0.737 | Prostaglandin E2 agonist | 0.737 0 DBMET02637 | DBMET02637 | |
| 0.667 | 0.005 | 0.678 | Vasodilator | 0.678 0.005 DBMET02637 | DBMET02637 | |
| 0.662 | 0.001 | 0.754 | Prostaglandin EP4 antagonist | 0.754 0.001 DBMET02637 | DBMET02637 | |
| 0.62 | 0.01 | 0.644 | Immunomodulator | 0.644 0.008 DBMET02637 | DBMET02637 | |
| 0.609 | 0.005 | 0.632 | Platelet aggregation inhibitor | 0.632 0.005 DBMET02637 | DBMET02637 | |
| 0.597 | 0 | 0.705 | Prostaglandin EP2 agonist | 0.705 0 DBMET02637 | DBMET02637 | |
| 0.561 | 0.003 | 0.628 | Prostaglandin E2 antagonist | 0.628 0.003 DBMET02637 | DBMET02637 | |
| 0.551 | 0.005 | 0.576 | Hepatoprotectant | 0.576 0.005 DBMET02637 | DBMET02637 | |
| 0.548 | 0.004 | 0.548 | Interferon gamma antagonist | 0.536 0.004 DBMET02637 | ||
| 0.536 | 0.003 | 0.56 | Neurotrophic factor | 0.56 0.003 DBMET02637 | DBMET02637 | |
| 0.526 | 0.017 | 0.534 | Caspase 3 stimulant | 0.534 0.016 DBMET02637 | DBMET02637 | |
| 0.534 | 0.027 | 0.538 | Cholesterol antagonist | 0.538 0.027 DBMET02637 | DBMET02637 | |
| 0.513 | 0.011 | 0.532 | Hypolipemic | 0.532 0.01 DBMET02637 | DBMET02637 | |
| 0.491 | 0.002 | 0.523 | Prostaglandin EP3 antagonist | 0.523 0.002 DBMET02637 | DBMET02637 | |
| 0.48 | 0.004 | 0.625 | Prostaglandin antagonist | 0.625 0.003 DBMET02637 | DBMET02637 | |
| 0.536 | 0.073 | 0.549 | Antiinflammatory | 0.549 0.069 DBMET02637 | DBMET02637 | |
| 0.478 | 0.032 | 0.481 | Immunostimulant | 0.481 0.031 DBMET02637 | DBMET02637 | |
| 0.511 | 0.071 | 0.511 | Apoptosis agonist | 0.482 0.08 DBMET02637 | ||
| 0.419 | 0.001 | 0.457 | Prostaglandin D2 agonist | 0.457 0.001 DBMET02637 | DBMET02637 | |
| 0.425 | 0.009 | 0.435 | Platelet adhesion inhibitor | 0.435 0.009 DBMET02637 | DBMET02637 | |
| 0.422 | 0.007 | 0.422 | Protein kinase stimulant | 0.322 0.014 DBMET02637 | ||
| 0.407 | 0.005 | 0.407 | Bronchodilator | 0.4 0.005 DBMET02637 | ||
| 0.396 | 0.001 | 0.461 | Prostacyclin agonist | 0.461 0.001 DBMET02637 | DBMET02637 | |
| 0.445 | 0.054 | 0.445 | Transcription factor NF kappa B inhibitor | 0.39 0.066 DBMET02637 | ||
| 0.408 | 0.025 | 0.471 | Interleukin 2 agonist | 0.471 0.012 DBMET02637 | DBMET02637 | |
| 0.372 | 0.003 | 0.506 | Prostaglandin EP1 antagonist | 0.506 0.003 DBMET02637 | DBMET02637 | |
| 0.364 | 0.001 | 0.461 | Prostaglandin EP4 agonist | 0.461 0 DBMET02637 | DBMET02637 | |
| 0.363 | 0.003 | 0.438 | Prostaglandin F2 alpha antagonist | 0.438 0.002 DBMET02637 | DBMET02637 | |
| 0.372 | 0.014 | 0.372 | Melanin inhibitor | 0.365 0.015 DBMET02637 | ||
| 0.342 | 0.008 | 0.375 | Cholesterol synthesis inhibitor | 0.375 0.005 DBMET02637 | DBMET02637 | |
| 0.363 | 0.043 | 0.363 | Antioxidant | 0.361 0.043 DBMET02637 | ||
| 0.339 | 0.033 | 0.339 | Nitric oxide antagonist | 0.327 0.036 DBMET02637 | ||
| 0.325 | 0.037 | 0.416 | Interleukin agonist | 0.416 0.016 DBMET02637 | DBMET02637 | |
| 0.299 | 0.017 | 0.337 | Bone formation stimulant | 0.337 0.014 DBMET02637 | DBMET02637 | |
| 0.369 | 0.091 | 0.373 | Antibacterial | 0.373 0.089 DBMET02637 | DBMET02637 | |
| 0.379 | 0.103 | 0.478 | Cyclophilin D inhibitor | 0.478 0.057 DBMET02637 | DBMET02637 | |
| 0.266 | 0 | 0.284 | Prostaglandin F2 alpha agonist | 0.284 0 DBMET02637 | DBMET02637 | |
| 0.297 | 0.034 | 0.297 | Anesthetic general | 0.248 0.051 DBMET02637 | ||
| 0.299 | 0.05 | 0.319 | Angiogenesis stimulant | 0.319 0.042 DBMET02637 | DBMET02637 | |
| 0.254 | 0.013 | 0.254 | Interleukin 4 antagonist | 0.204 0.021 DBMET02637 | ||
| 0.241 | 0.011 | 0.241 | Microtubule formation inhibitor | 0.217 0.016 DBMET02637 | ||
| 0.236 | 0.019 | 0.236 | DNA polymerase I inhibitor | 0.232 0.02 DBMET02637 | ||
| 0.232 | 0.024 | 0.263 | Hemostatic | 0.263 0.02 DBMET02637 | DBMET02637 | |
| 0.292 | 0.086 | 0.344 | Sodium/bile acid cotransporter inhibitor | 0.344 0.044 DBMET02637 | DBMET02637 | |
| 0.264 | 0.063 | 0.264 | Free radical scavenger | 0.244 0.071 DBMET02637 | ||
| 0.293 | 0.093 | 0.293 | Vasodilator, coronary | 0.28 0.104 DBMET02637 | ||
| 0.264 | 0.069 | 0.294 | Hypoglycemic | 0.294 0.055 DBMET02637 | DBMET02637 | |
| 0.212 | 0.023 | 0.218 | Arachidonic acid antagonist | 0.218 0.019 DBMET02637 | DBMET02637 | |
| 0.272 | 0.086 | 0.272 | Lipoxygenase inhibitor | 0.233 0.112 DBMET02637 | ||
| 0.195 | 0.009 | 0.195 | Electron transport complex I inhibitor | 0.188 0.01 DBMET02637 | ||
| 0.219 | 0.033 | 0.227 | Phospholipase A2 inhibitor | 0.227 0.03 DBMET02637 | DBMET02637 | |
| 0.251 | 0.065 | 0.271 | DNA synthesis inhibitor | 0.271 0.055 DBMET02637 | DBMET02637 | |
| 0.189 | 0.008 | 0.19 | T cell inhibitor | 0.19 0.008 DBMET02637 | DBMET02637 | |
| 0.28 | 0.1 | 0.297 | Apoptosis antagonist | 0.297 0.087 DBMET02637 | DBMET02637 | |
| 0.195 | 0.016 | 0.22 | Adenylate cyclase stimulant | 0.22 0.007 DBMET02637 | DBMET02637 | |
| 0.191 | 0.015 | 0.191 | Photosensitizer | 0.16 0.025 DBMET02637 | ||
| 0.179 | 0.005 | 0.181 | Glycine receptor agonist | 0.181 0.005 DBMET02637 | DBMET02637 | |
| 0.242 | 0.078 | 0.242 | Tumour necrosis factor alpha release inhibitor | 0.155 0.152 DBMET02637 | ||
| 0.203 | 0.04 | 0.207 | Lipid peroxidase inhibitor | 0.207 0.039 DBMET02637 | DBMET02637 | |
| 0.17 | 0.009 | 0.187 | Anabolic | 0.187 0.006 DBMET02637 | DBMET02637 | |
| 0.189 | 0.036 | 0.189 | Monophenol monooxygenase inhibitor | 0.161 0.043 DBMET02637 | ||
| 0.205 | 0.053 | 0.255 | Lipocortins synthesis antagonist | 0.255 0.032 DBMET02637 | DBMET02637 | |
| 0.149 | 0.001 | 0.203 | Thromboxane agonist | 0.203 0.001 DBMET02637 | DBMET02637 | |
| 0.207 | 0.066 | 0.216 | Insulin sensitizer | 0.216 0.058 DBMET02637 | DBMET02637 | |
| 0.155 | 0.018 | 0.155 | Toll-Like receptor 4 antagonist | 0.116 0.048 DBMET02637 | ||
| 0.141 | 0.004 | 0.247 | Prostacyclin antagonist | 0.247 0.003 DBMET02637 | DBMET02637 | |
| 0.163 | 0.028 | 0.163 | Antineoplastic antibiotic | 0.16 0.029 DBMET02637 | ||
| 0.139 | 0.005 | 0.164 | Thromboxane antagonist | 0.164 0.004 DBMET02637 | DBMET02637 | |
| 0.181 | 0.06 | 0.196 | Phospholipase C inhibitor | 0.196 0.047 DBMET02637 | DBMET02637 | |
| 0.153 | 0.035 | 0.163 | Ca2+-transporting ATPase inhibitor | 0.163 0.02 DBMET02637 | DBMET02637 | |
| 0.13 | 0.013 | 0.15 | Leukotriene antagonist | 0.15 0.01 DBMET02637 | DBMET02637 | |
| 0.149 | 0.035 | 0.156 | Papain-like protease (SARS coronavirus) inhibitor | 0.156 0.029 DBMET02637 | DBMET02637 | |
| 0.131 | 0.018 | 0.131 | Interleukin 5 antagonist | 0.11 0.031 DBMET02637 | ||
| 0.152 | 0.043 | 0.222 | Adenylate cyclase inhibitor | 0.222 0.022 DBMET02637 | DBMET02637 | |
| 0.114 | 0.008 | 0.139 | Leukotriene B4 antagonist | 0.139 0.005 DBMET02637 | DBMET02637 | |
| 0.217 | 0.114 | 0.217 | Transcription factor STAT3 inhibitor | |||
| 0.17 | 0.07 | 0.17 | ATPase inhibitor | 0.148 0.105 DBMET02637 | ||
| 0.131 | 0.033 | 0.131 | Antineoplastic alkaloid | 0.099 0.048 DBMET02637 | ||
| 0.116 | 0.019 | 0.116 | Na+ K+ transporting ATPase inhibitor | 0.115 0.019 DBMET02637 | ||
| 0.103 | 0.007 | 0.103 | Nitric oxide donor | 0.102 0.008 DBMET02637 | ||
| 0.117 | 0.021 | 0.117 | ATPase (Vacuolar H+) inhibitor | 0.109 0.029 DBMET02637 | ||
| 0.142 | 0.047 | 0.15 | Vanilloid 1 agonist | 0.15 0.038 DBMET02637 | DBMET02637 | |
| 0.167 | 0.075 | 0.282 | Growth hormone agonist | 0.282 0.036 DBMET02637 | DBMET02637 | |
| 0.097 | 0.008 | 0.112 | Thromboxane A2 antagonist | 0.112 0.005 DBMET02637 | DBMET02637 | |
| 0.118 | 0.032 | 0.134 | ABCA1 expression enhancer | 0.134 0.023 DBMET02637 | DBMET02637 | |
| 0.108 | 0.023 | 0.108 | Interferon agonist | 0.093 0.035 DBMET02637 | ||
| 0.107 | 0.026 | 0.143 | Glycine receptor antagonist | 0.143 0.009 DBMET02637 | DBMET02637 | |
| 0.129 | 0.057 | 0.144 | Protein-tyrosine phosphatase 1B inhibitor | 0.144 0.048 DBMET02637 | DBMET02637 | |
| 0.154 | 0.083 | 0.154 | Sigma receptor agonist | 0.138 0.094 DBMET02637 | ||
| 0.088 | 0.018 | 0.088 | Interferon inducer | 0.07 0.035 DBMET02637 | ||
| 0.066 | 0.001 | 0.085 | Thromboxane A2 agonist | 0.085 0.001 DBMET02637 | DBMET02637 | |
| 0.136 | 0.072 | 0.144 | Farnesoid X receptor antagonist | 0.144 0.06 DBMET02637 | DBMET02637 | |
| 0.16 | 0.102 | 0.16 | P-glycoprotein inhibitor | |||
| 0.078 | 0.02 | 0.084 | Protein 50S ribosomal subunit inhibitor | 0.084 0.018 DBMET02637 | DBMET02637 | |
| 0.168 | 0.113 | 0.188 | Neurotrophic factor enhancer | 0.188 0.089 DBMET02637 | DBMET02637 | |
| 0.141 | 0.089 | 0.15 | Protein-tyrosine phosphatase inhibitor | 0.15 0.078 DBMET02637 | DBMET02637 | |
| 0.057 | 0.005 | 0.062 | HMG CoA reductase inhibitor | 0.062 0.005 DBMET02637 | DBMET02637 | |
| 0.148 | 0.097 | 0.189 | Antipruritic | 0.189 0.057 DBMET02637 | DBMET02637 | |
| 0.07 | 0.021 | 0.07 | Lipocortins synthesis agonist | 0.07 0.021 DBMET02637 | ||
| 0.097 | 0.048 | 0.1 | Ornithine decarboxylase inhibitor | 0.1 0.044 DBMET02637 | DBMET02637 | |
| 0.048 | 0.003 | 0.06 | Vitamin D receptor agonist | 0.06 0.002 DBMET02637 | DBMET02637 | |
| 0.05 | 0.008 | 0.132 | ATP citrate lysase inhibitor | 0.132 0.003 DBMET02637 | DBMET02637 | |
| 0.054 | 0.016 | 0.061 | Parathyroid hormone antagonist | 0.061 0.01 DBMET02637 | DBMET02637 | |
| 0.174 | 0.139 | 0.203 | Peptidyltransferase inhibitor | 0.203 0.095 DBMET02637 | DBMET02637 | |
| 0.038 | 0.005 | 0.042 | Vitamin D receptor antagonist | 0.042 0.005 DBMET02637 | DBMET02637 | |
| 0.048 | 0.017 | 0.064 | Membrane dipeptidase inhibitor | 0.064 0.009 DBMET02637 | DBMET02637 | |
| 0.04 | 0.01 | 0.04 | Calcium-independent phospholipase A2 inhibitor | 0.037 0.015 DBMET02637 | ||
| 0.079 | 0.052 | 0.087 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.087 0.046 DBMET02637 | DBMET02637 | |
| 0.069 | 0.045 | 0.074 | Leukotriene synthesis inhibitor | 0.074 0.041 DBMET02637 | DBMET02637 | |
| 0.127 | 0.103 | 0.155 | NOS3 expression enhancer | 0.155 0.067 DBMET02637 | DBMET02637 | |
| 0.048 | 0.03 | 0.048 | Microtubule stabilization | 0.047 0.032 DBMET02637 | ||
| 0.109 | 0.091 | 0.109 | Toll-Like receptor 2 antagonist | |||
| 0.049 | 0.031 | 0.08 | Glucose-6-phosphate isomerase inhibitor | 0.08 0.009 DBMET02637 | DBMET02637 | |
| 0.067 | 0.05 | 0.162 | Phosphofructokinase-1 inhibitor | 0.162 0.016 DBMET02637 | DBMET02637 | |
| 0.02 | 0.003 | 0.02 | Calcineurin inhibitor | 0.019 0.004 DBMET02637 | ||
| 0.038 | 0.021 | 0.05 | Fumarate hydratase inhibitor | 0.05 0.014 DBMET02637 | DBMET02637 | |
| 0.03 | 0.018 | 0.046 | Leukotriene B4 receptor 1 antagonist | 0.046 0.009 DBMET02637 | DBMET02637 | |
| 0.033 | 0.021 | 0.039 | Squalene synthetase inhibitor | 0.039 0.019 DBMET02637 | DBMET02637 | |
| 0.123 | 0.113 | 0.123 | Hexokinase inhibitor | |||
| 0.023 | 0.014 | 0.034 | Leukotriene B4 receptor 2 antagonist | 0.034 0.007 DBMET02637 | DBMET02637 | |
| 0.021 | 0.014 | 0.021 | Neuraminidase (Influenza B) inhibitor | 0.021 0.013 DBMET02637 | ||
| 0.03 | 0.023 | 0.03 | Elastase 3B inhibitor | |||
| 0.03 | 0.023 | 0.03 | Elastase 2B inhibitor | |||
| 0.03 | 0.023 | 0.03 | Elastase 3A inhibitor | |||
| 0.044 | 0.038 | 0.051 | Peroxisome proliferator-activated receptor alpha agonist | 0.051 0.031 DBMET02637 | DBMET02637 | |
| 0.138 | 0.133 | 0.138 | Non-steroidal antiinflammatory agent | 0.138 0.134 DBMET02637 | ||
| 0.078 | 0.073 | 0.078 | Transcription factor NF kappa B stimulant | |||
| 0.061 | 0.057 | 0.083 | Peroxisome proliferator-activated receptor gamma agonist | 0.083 0.039 DBMET02637 | DBMET02637 | |
| 0.026 | 0.024 | 0.028 | RNA-directed RNA polymerase stimulant | 0.028 0.022 DBMET02637 | DBMET02637 | |
| 0.003 | 0.003 | 0.004 | Vitamin D-like | 0.004 0.003 DBMET02637 | DBMET02637 | |
| 0.061 | 0.062 | 0.084 | Glutamate (mGluR6) antagonist | 0.084 0.02 DBMET02637 | DBMET02637 | |
| 0.077 | 0.079 | 0.08 | Vanilloid agonist | 0.08 0.071 DBMET02637 | DBMET02637 | |
| 0.064 | 0.069 | 0.079 | CDC25A inhibitor | 0.079 0.044 DBMET02637 | DBMET02637 | |
| 0.197 | 0.205 | 0.226 | Toll-Like receptor agonist | 0.226 0.172 DBMET02637 | DBMET02637 | |
| 0.038 | 0.048 | 0.043 | Neuraminidase (Influenza A) inhibitor | 0.043 0.036 DBMET02637 | DBMET02637 | |
| 0.035 | 0.051 | 0.048 | Kainate receptor agonist | 0.048 0.017 DBMET02637 | DBMET02637 | |
| 0.044 | 0.067 | 0.057 | Thromboxane synthase inhibitor | 0.057 0.033 DBMET02637 | DBMET02637 | |
| 0.048 | 0.072 | 0.055 | Pregnane X receptor antagonist | 0.055 0.043 DBMET02637 | DBMET02637 | |
| 0.028 | 0.056 | 0.037 | Glutamate (mGluR8) antagonist | 0.037 0.022 DBMET02637 | DBMET02637 | |
| 0.038 | 0.069 | 0.109 | Argininosuccinate synthase inhibitor | 0.109 0.017 DBMET02637 | DBMET02637 | |
| 0.046 | 0.078 | 0.061 | Sphingosine kinase inhibitor | 0.061 0.037 DBMET02637 | DBMET02637 | |
| 0.082 | 0.116 | 0.097 | Folate antagonist | 0.097 0.07 DBMET02637 | DBMET02637 | |
| 0.047 | 0.084 | 0.056 | Leukotriene C antagonist | 0.056 0.04 DBMET02637 | DBMET02637 | |
| 0.014 | 0.056 | 0.04 | Arginase inhibitor | 0.04 0.023 DBMET02637 | DBMET02637 | |
| 0.164 | 0.216 | 0.213 | Tyrosine 3 hydroxylase inhibitor | 0.213 0.114 DBMET02637 | DBMET02637 | |
| 0.084 | 0.136 | 0.099 | Cell adhesion inhibitor | 0.099 0.09 DBMET02637 | DBMET02637 | |
| 0.049 | 0.107 | 0.087 | Glutamate dehydrogenase inhibitor | 0.087 0.039 DBMET02637 | DBMET02637 | |
| 0.032 | 0.095 | 0.058 | Aconitate hydratase inhibitor | 0.058 0.028 DBMET02637 | DBMET02637 | |
| 0.074 | 0.141 | 0.113 | Adenylate kinase inhibitor | 0.113 0.05 DBMET02637 | DBMET02637 | |
| 0.172 | 0.242 | 0.205 | Toll-Like receptor 7 agonist | 0.205 0.194 DBMET02637 | DBMET02637 | |
| 0.068 | 0.146 | 0.105 | Amylase inhibitor | 0.105 0.092 DBMET02637 | DBMET02637 | |
| 0.028 | 0.123 | 0.071 | Carbamoyl phosphate synthetase inhibitor | 0.071 0.034 DBMET02637 | DBMET02637 | |
| 0.11 | 0.208 | 0.166 | Succinate dehydrogenase inhibitor | 0.166 0.086 DBMET02637 | DBMET02637 | |
| 0.056 | 0.154 | 0.112 | Triose-phosphate isomerase inhibitor | 0.112 0.037 DBMET02637 | DBMET02637 | |
| 0.158 | 0.265 | 0.212 | 5 Hydroxytryptamine uptake stimulant | 0.212 0.129 DBMET02637 | DBMET02637 | |
| 0.153 | 0.279 | 0.234 | Histamine release inhibitor | 0.234 0.168 DBMET02637 | DBMET02637 | |
| 0.043 | 0.218 | 0.117 | GABA C receptor agonist | 0.117 0.052 DBMET02637 | DBMET02637 | |
| 0.045 | 0.222 | 0.082 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.082 0.077 DBMET02637 | DBMET02637 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |